Clinical Trials

  • Principal Investigator:

    Elizabeth Christine Oelsner, MD
    This study is called the COVID-19 Lung Microvascular and Parenchymal Sequelae (LUNG MaPS) Study. The purpose of the study is to learn about the effects of COVID-19 infections on the lungs and heart, and to improve our understanding of why some COVID-19 patients experience ongoing symptoms, or what is often called "long COVID." Hundreds of thousands of Americans have been infected with COVID-19. We still know relatively little about what COVID-19 might do to the lungs and heart in the long term, or why some patients have symptoms for many months after their infection. This study is designed...
  • Principal Investigator:

    Jose A. Luchsinger, MD
    The purpose of NOMEM is to learn more about how blood sugar and other factors relate to the brain and mental abilities of persons living in Northern Manhattan. We are seeking your help to conduct this study. Participation will include these activities: 1. Questionnaires 2. Blood tests 3. A brain MRI 4. A brain PET scan with contrast. We will compensate your time for participating in these 4 activities with $350. We will also give you the results of important blood tests.
  • Principal Investigator:

    Jose A. Luchsinger, MD
    MAP is a research study looking at whether metformin can help prevent memory decline for people with mild memory concerns. You may be able to join if: you are 55-90 years old, you or your loved ones have noticed some changes in your memory, and you are not already being treated for diabetes or dementia. Potential benefits: You will receive some of your blood test results. We can also share these results with your healthcare provider. Your participation may improve the prevention of dementia for future generations.